(Q40644706)

22 September 2017

title

Safety and efficacy of flumazenil in the reversal of benzodiazepine-induced conscious sedation. The Flumazenil Pediatric Study Group (English)

1 reference

22 September 2017

Shannon M

1

1 reference

22 September 2017

Albers G

2

1 reference

22 September 2017

Burkhart K

3

1 reference

22 September 2017

Liebelt E

4

1 reference

22 September 2017

Kelley M

5

1 reference

22 September 2017

McCubbin MM

6

1 reference

22 September 2017

Hoffman J

7

1 reference

22 September 2017

Massarella J

8

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

The Journal of Pediatrics

22 September 2017

published in

1 reference

22 September 2017

volume

131

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

582-586

1 reference

Nasal versus oral midazolam for sedation of anxious children undergoing laceration repair

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970066-0

Sedation for the pediatric patient. A review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970066-0

A comparison of intranasal sufentanil and midazolam to intramuscular meperidine, promethazine, and chlorpromazine for conscious sedation in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970066-0

Combination fentanyl and diazepam for pediatric conscious sedation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970066-0

Flumazenil: a new benzodiazepine antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970066-0

Flumazenil. A reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970066-0

Antagonism of the hypnotic effect of midazolam in children: a randomized, double-blind study of placebo and flumazenil administered after midazolam-induced anaesthesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970066-0

The use of flumazenil in a neonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970066-0

Clinical evaluation of a specific benzodiazepine antagonist (RO 15-1788). Studies in elderly patients after regional anaesthesia under benzodiazepine sedation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970066-0

The effects of flumazenil, a new benzodiazepine antagonist, on the reversal of midazolam sedation and amnesia in dental patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970066-0

Pharmacokinetics of flumazenil and midazolam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970066-0

10.1016/S0022-3476(97)70066-0

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference